Recombinant ITGA4, ITGB7 (Vedolizumab Biosimilar) antibody

Catalog No. ABIN7598086

The Humanized Chimeric anti-ITGA4, ITGB7 (Vedolizumab Biosimilar) antibody has been validated for . It is suitable to detect ITGA4, ITGB7 (Vedolizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant ITGA4, ITGB7 (Vedolizumab Biosimilar) antibody (ABIN7598086)

Target: ITGA4, ITGB7 (Vedolizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This ITGA4, ITGB7 (Vedolizumab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-ITGA4, ITGB7 (Vedolizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Vedolizumab Biosimilar Antibody

Specificity: ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4, Gut homing receptor beta subunit, Integrin beta-7, ITGB7

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for ITGA4, ITGB7 (Vedolizumab Biosimilar)

Target: ITGA4, ITGB7 (Vedolizumab Biosimilar)

Alternative Name: Vedolizumab Biosimilar

Target Type: Biosimilar

Background: ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4, Gut homing receptor beta subunit, Integrin beta-7, ITGB7

UniProt: P13612, P26010

CAS-No: 943609-66-3